Scandinavian Medical Solutions A/S

Symbol: SMSMED.CO

CPH

7.5

DKK

Market price today

  • 11.3520

    P/E Ratio

  • -0.1374

    PEG Ratio

  • 206.26M

    MRK Cap

  • 0.00%

    DIV Yield

Scandinavian Medical Solutions A/S (SMSMED-CO) Financial Statements

On the chart you can see the default numbers in dynamics for Scandinavian Medical Solutions A/S (SMSMED.CO). Companys revenue shows the average of 89.301 M which is 0.465 % gowth. The average gross profit for the whole period is 16.688 M which is 0.518 %. The average gross profit ratio is 0.182 %. The net income growth for the company last year performance is 0.075 % which equals 0.352 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Scandinavian Medical Solutions A/S, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.545. In the realm of current assets, SMSMED.CO clocks in at 115.097 in the reporting currency. A significant portion of these assets, precisely 7.918, is held in cash and short-term investments. This segment shows a change of -0.715% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 48.279, if any, in the reporting currency. This indicates a difference of 267.709% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 17.69 in the reporting currency. This figure signifies a year_over_year change of 269.975%. Shareholder value, as depicted by the total shareholder equity, is valued at 74.451 in the reporting currency. The year over year change in this aspect is 0.197%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 23.983, with an inventory valuation of 83.2, and goodwill valued at 0, if any. The total intangible assets, if present, are valued at 0. Account payables and short-term debt are 33.68 and 10.91, respectively. The total debt is 28.6, with a net debt of 20.69. Other current liabilities amount to 3.83, adding to the total liabilities of 89.51. Lastly, the referred stock is valued at 0, if it exists.

common:word.in-mln

USD
Growth
TTM20232022202120202019

balance-sheet.row.cash-and-short-term-investments

19.257.927.825.4
10.7
4.1

balance-sheet.row.short-term-investments

0000
0
0

balance-sheet.row.net-receivables

67.952413.42.8
2.7
0

balance-sheet.row.inventory

303.7483.251.514.4
3.6
2.7

balance-sheet.row.other-current-assets

11.71000
0
0

balance-sheet.row.total-current-assets

402.64115.192.744.3
17
9.3

balance-sheet.row.property-plant-equipment-net

166.6748.313.10
0
0

balance-sheet.row.goodwill

0000
0
0

balance-sheet.row.intangible-assets

0000
0
0

balance-sheet.row.goodwill-and-intangible-assets

0000
0
0

balance-sheet.row.long-term-investments

75.2748.313.10.3
0
0

balance-sheet.row.tax-assets

0000
0
0

balance-sheet.row.other-non-current-assets

-72.89-47.7-12.80
0
0

balance-sheet.row.total-non-current-assets

169.0548.913.50.3
0.1
0

balance-sheet.row.other-assets

0000
0
0

balance-sheet.row.total-assets

571.7164106.144.6
17.1
9.4

balance-sheet.row.account-payables

100.9233.725.47.3
8.1
5.3

balance-sheet.row.short-term-debt

20.8410.90.1-9
0.3
0.1

balance-sheet.row.tax-payables

11.676.92.42.4
2.2
0.9

balance-sheet.row.long-term-debt-total

51.9217.700
0
0

Deferred Revenue Non Current

-0.96000
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0.96---
-
-

balance-sheet.row.other-current-liab

62.633.80.613.2
2.2
0.9

balance-sheet.row.total-non-current-liabilities

55.1317.73.60
0
0

balance-sheet.row.other-liabilities

0000
0
0

balance-sheet.row.capital-lease-obligations

62.2921.100
0
0

balance-sheet.row.total-liab

279.3789.543.920.5
12.2
6.2

balance-sheet.row.preferred-stock

0000
0
0

balance-sheet.row.common-stock

4.371.11.10.8
0.1
0

balance-sheet.row.retained-earnings

287.9573.461.123.3
4.8
3

balance-sheet.row.accumulated-other-comprehensive-income-loss

0000
0
0

balance-sheet.row.other-total-stockholders-equity

0000
0
0.1

balance-sheet.row.total-stockholders-equity

292.3374.562.224.1
4.9
3.1

balance-sheet.row.total-liabilities-and-stockholders-equity

571.7164106.144.6
17.1
9.4

balance-sheet.row.minority-interest

0000
0
0

balance-sheet.row.total-equity

292.3374.562.224.1
4.9
3.1

balance-sheet.row.total-liabilities-and-total-equity

571.7---
-
-

Total Investments

75.2748.313.10.3
0
0

balance-sheet.row.total-debt

72.7628.60.10
0.3
0.1

balance-sheet.row.net-debt

53.5220.7-27.7-25.4
-10.4
-4

Cash Flow Statement

The financial landscape of Scandinavian Medical Solutions A/S has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -1.022. The company recently extended its share capital by issuing 0.07, marking a difference of 0.245 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 0 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -39866002.000 in the reporting currency. This is a shift of 1.896 from the previous year. In the same period, the company recorded 4.46, 1.24, and -22.73, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated 0 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 43.85, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2023202220212020

cash-flows.row.net-income

18.3416.614.710.9
4.5

cash-flows.row.depreciation-and-amortization

6.684.50.60
0

cash-flows.row.deferred-income-tax

0000
0

cash-flows.row.stock-based-compensation

0000
0

cash-flows.row.change-in-working-capital

-39.58-26.4-25.7-4.4
3.5

cash-flows.row.account-receivables

0000
0

cash-flows.row.inventory

0000
0

cash-flows.row.account-payables

0000
0

cash-flows.row.other-working-capital

-39.58-26.400
0

cash-flows.row.other-non-cash-items

2.01-3.1-0.2-2.5
1.3

cash-flows.row.net-cash-provided-by-operating-activities

-12.55000
0

cash-flows.row.investments-in-property-plant-an-equipment

-61.23-40.8-13.80
0

cash-flows.row.acquisitions-net

1.241.200
0

cash-flows.row.purchases-of-investments

-0.29-0.30-0.3
0

cash-flows.row.sales-maturities-of-investments

0-1.200
0

cash-flows.row.other-investing-activites

0.481.200
0

cash-flows.row.net-cash-used-for-investing-activites

-59.8-39.9-13.8-0.3
0

cash-flows.row.debt-repayment

0-22.700
0

cash-flows.row.common-stock-issued

0.040.13019.5
-2.8

cash-flows.row.common-stock-repurchased

0000
0

cash-flows.row.dividends-paid

000-4.5
0

cash-flows.row.other-financing-activites

21.1943.9-3.3-3.9
0

cash-flows.row.net-cash-used-provided-by-financing-activities

31.7821.226.711.1
-2.8

cash-flows.row.effect-of-forex-changes-on-cash

-0.26-0.300
0

cash-flows.row.net-change-in-cash

-33.5-27.32.414.8
6.6

cash-flows.row.cash-at-end-of-period

-4.030.527.825.4
10.7

cash-flows.row.cash-at-beginning-of-period

29.4727.825.410.6
4.1

cash-flows.row.operating-cash-flow

-12.55-8.4-10.64
9.4

cash-flows.row.capital-expenditure

-61.23-40.8-13.80
0

cash-flows.row.free-cash-flow

-73.78-49.2-24.34
9.4

Income Statement Row

Scandinavian Medical Solutions A/S's revenue saw a change of 0.730% compared with the previous period. The gross profit of SMSMED.CO is reported to be 34.73. The company's operating expenses are 18.1, showing a change of 128.026% from the last year. The expenses for depreciation and amortization are 4.46, which is a 6.309% change from the last accounting period. Operating expenses are reported to be 18.1, which shows a 128.026% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.128% year-over-year growth. The operating income is 16.63, which shows a 0.128% change when compared to the previous year. The change in the net income is 0.075%. The net income for the last year was 12.22.

common:word.in-mln

USD
Growth
TTM20232022202120202019

income-statement-row.row.total-revenue

286.79191.2110.571.6
41.9
31.2

income-statement-row.row.cost-of-revenue

238.14156.587.957.8
34.6
26.4

income-statement-row.row.gross-profit

48.6534.722.713.9
7.4
4.8

income-statement-row.row.gross-profit-ratio

0000
0
0

income-statement-row.row.research-development

0---
-
-

income-statement-row.row.selling-general-administrative

0---
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-

income-statement-row.row.other-expenses

0000
0
0

income-statement-row.row.operating-expenses

23.6418.17.93
1.4
0.9

income-statement-row.row.cost-and-expenses

261.78174.695.860.8
36
27.3

income-statement-row.row.interest-income

1.310.10.20.2
0.1
0

income-statement-row.row.interest-expense

1.3310.30.5
0.3
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-

income-statement-row.row.total-other-income-expensenet

-1.25-0.80-0.3
-0.1
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-

income-statement-row.row.other-operating-expenses

0000
0
0

income-statement-row.row.total-operating-expenses

-1.25-0.80-0.3
-0.1
0

income-statement-row.row.interest-expense

1.3310.30.5
0.3
0

income-statement-row.row.depreciation-and-amortization

6.684.50.60
0
0

income-statement-row.row.ebitda-caps

31.62---
-
-

income-statement-row.row.operating-income

24.9416.614.710.9
6
3.9

income-statement-row.row.income-before-tax

23.6915.814.710.5
5.8
3.9

income-statement-row.row.income-tax-expense

5.353.63.32.4
1.3
0.9

income-statement-row.row.net-income

18.3412.211.48.2
4.5
3

Frequently Asked Question

What is Scandinavian Medical Solutions A/S (SMSMED.CO) total assets?

Scandinavian Medical Solutions A/S (SMSMED.CO) total assets is 163964159.000.

What is enterprise annual revenue?

The annual revenue is 142427685.000.

What is firm profit margin?

Firm profit margin is 0.170.

What is company free cash flow?

The free cash flow is -2.701.

What is enterprise net profit margin?

The net profit margin is 0.064.

What is firm total revenue?

The total revenue is 0.087.

What is Scandinavian Medical Solutions A/S (SMSMED.CO) net profit (net income)?

The net profit (net income) is 12224314.000.

What is firm total debt?

The total debt is 28603601.000.

What is operating expences number?

The operating expences are 18102578.000.

What is company cash figure?

Enretprise cash is 7918300.000.